Dr. Jason R. McLaughlin, MD

Dr. McLaughlin practices at Jefferson Abington Hospital in Abington, Pennsylvania, part of Thomas Jefferson University.

Dr. McLaughlin's NPI, 1649223363, was assigned on May 17, 2006. Dr. McLaughlin holds Pennsylvania license MD428703.

Dr. McLaughlin's primary practice is Jefferson Abington Hospital, at 1200 Old York Road, Abington, PA 19001 in Montgomery County. The practice phone is (215) 481-2000.

Dr. McLaughlin's primary practice is Jefferson Abington Hospital in Abington, Pennsylvania, part of Thomas Jefferson University. The medical group on file is Abington Emergency Physician Associates (AEPA).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McLaughlin practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. McLaughlin's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. McLaughlin is licensed in Pennsylvania.

CMS data shows 1,096 Medicare services from Dr. McLaughlin across 4 procedure codes in 2024, for 738 Medicare patients. Medicare paid $105,487 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 738 Medicare patients who saw Dr. McLaughlin in 2024. The largest group is 75 to 84, with 279 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McLaughlin's median patient age at 65, with 58% women.

In 2024, Dr. McLaughlin wrote 121 Medicare Part D claims for 90 patients. 98% of them were for generic drugs. CMS names the drug for 40 of them, across 2 drugs with 11 or more claims each, at $156 in total drug cost. In 2023, CMS named 32 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. McLaughlin for performance year 2024, reported as part of a group.

CMS Open Payments shows 7 general payments to Dr. McLaughlin from 3 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $45.